Citations 223

Faculty Opinions recommendation of Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726176062.793546415

Faculty Opinions recommendation of Lung transplantation for lymphangioleiomyomatosis in japan.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726076830.793546417

Faculty Opinions recommendation of Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.731932404.793546411

Faculty Opinions recommendation of Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727301567.793546412

Faculty Opinions recommendation of Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726630482.793546409

Faculty Opinions recommendation of The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725757738.793546406

Faculty Opinions recommendation of Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.723347495.793546407

Faculty Opinions recommendation of Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.9404956.793546405

Faculty Opinions recommendation of European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.722035556.793546404

Constrictive Bronchiolitis in Patients With Primary Sjögren Syndrome

JCR: Journal of Clinical Rheumatology | March 29, 2018 | Volume: 25 | Issue: 2 | Pages: 74-77

10.1097/rhu.0000000000000771 | PMID 29596206

ObjectiveConstrictive bronchiolitis (CB) is a poorly understood pulmonary manifestation of primary Sjögren syndrome (pSS). We aimed to clarify the presenting clinicoradiologic features and clinical course of pSS-associated CB through a retrospective cohort study.MethodsWe retrospectively identified 11 patients with pSS and CB (defined by mosaic pattern with air trapping on computed tomography) encountered at our institution over 9 years from 2007 to 2015. Presenting clinical features, laboratory results, radiologic findings, and clinical course were analyzed.ResultsOur patients were mostly women (91%), with a median age 53 years (range, 31–76 years) at the time of pulmonary symptom (dyspnea or cough) onset. Most (64%) were nonsmokers. Average interval between diagnosis of pSS and the onset of pulmonary symptoms was 4.4 years; in 4 patients (36%), CB was the presenting manifestation of pSS. Chest radiographs were normal (67%) or demonstrated hyperinflation (33%). Pulmonary function testing demonstrated airflow obstruction in 7 patients (63%), and 2 patients (18%) had an isolated reduction in diffusing capacity, whereas the remaining 2 patients manifested mixed physiology or normal results. Surgical lung biopsy was performed in 2 patients and confirmed the diagnosis of CB in both. Treatment was variable among our patients included glucocorticoids, hydroxychloroquine, mycophenolate mofetil, and cyclophosphamide. Among 6 patients with follow-up computed tomography and pulmonary function, the results remained stable or worsened.ConclusionsConstrictive bronchiolitis is a rare extraglandular manifestation and can sometimes be the presenting manifestation of pSS. This pulmonary manifestation is associated with an indolent clinical course and does not respond well to immunosuppressive therapy.